From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.HRV Pharma buys Germany's Phatebo
What's behind this
HRV Pharma is acquiring Phatebo, a Germany‑based clinical trial supplier. The purchase will expand HRV Pharma’s operations beyond active pharmaceutical ingredients into finished formulations and provide the company with a licensed operating business in Germany.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
left · 1 outlet
The acquisition will take it beyond active pharmaceutical ingredients into finished formulations and give it a licensed operating business in Germany.
-
right · 2 outlets
The acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations, giving it its first finished formulations business alongside a licenced operating entity in Germany.
RSS excerpt
The acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations, giving it its first finished formulations business alongside a licenced operating entity in Germany.
